Navigating diabetes-related immune epitope data: Resources and tools provided by the immune epitope database (IEDB)

Immunome Research

Volumn 9, Issue 1, 2013, Pages

  Vaughan, Kerrie ^a   Peters, Bjoern ^a   Mallone, Roberto ^b   Von Herrath, Matthias ^a   Roep, Bart O ^c   Sette, Alessandro ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; EPITOPE; GLUCOSE 6 PHOSPHATASE; GLUTAMATE DECARBOXYLASE; HEAT SHOCK PROTEIN; INSULIN; INSULINOMA ANTIGEN 2; ISLET CELL AUTO ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN; PROTEIN TYROSINE PHOSPHATASE; TETRAMER; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8;

ALLELE; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BIBLIOGRAPHIC DATABASE; CELL ASSAY; CLINICAL FEATURE; DIABETES MELLITUS; HOST; HUMAN; INFORMATION RETRIEVAL; MAJOR HISTOCOMPATIBILITY COMPLEX; META ANALYSIS; T LYMPHOCYTE;

EID: 84896768066     PISSN: None     EISSN: 17457580     Source Type: Journal    
DOI: 10.4172/1745-7580.1000063     Document Type: Article

References (33)

1. Peters B, Sidney J, Bourne P, Bui HH, Buus S, Doh G, Fleri W, Kronenberg M, Kubo R, Lund O, Nemazee D, Ponomarenko JV, Sathi-amurthy M, Schoenberger S, Stewart S, Surko P, Way S, Wilson S, Sette A: The Immune Epitope Database and Analysis Resource: from Vision to Blueprint. PLoS Biol 2005, 3(3):e91.
2. Santamaria P: The long and winding road to understanding and conquering type 1 diabetes. Immunity 2010, 32:437-45.
3. + type 1 diabetic patients. Diabetologia 2012, 55:2026-2031.
4. Brezar V, Carel JC, Boitard C, Mallone R: Beyond the hormone: insulin as an autoimmune target in type 1 diabetes. Endocr Rev 2011, 32:623-669.
5. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B: The immune epitope database 2.0. Nucleic Acids Res 2010, 38:D854-62.
6. Peters B, Sidney J, Bourne P, Bui HH, Buus S, Doh G, Fleri W, Kronenberg M, Kubo R, Lund O, Nemazee D, Ponomarenko JV, Sathi-amurthy M, Schoenberger S, Stewart S, Surko P, Way S, Wilson S, Sette A: The Design and Implementation of the Immune Epitope Data Base and Analysis Resource. Immunogenetics 2005, 57(5):326-336.
7. Davies V, Vaughan K, Damle R, Peters B, Sette A: Classification of the universe of immune epitope literature: representation and knowledge gaps. PLoS ONE 2009, 4(11):e8084.
8. Seymour E, Damle R, Sette A, Peters B: Cost sensitive hierarchical document classification to triage PubMed abstracts for manual curation. BMC Bioinformatics 2011, 12:482.
9. Stadinski BD, Delong T, Reisdorph N, Reisdorph R, Powell RL, Arm-strong M, Piganelli JD, Barbour G, Bradley B, Crawford F, Marrack P, Mahata SK, Kappler JW, Haskins K: Chromogranin A is an autoanti-gen in type 1 diabetes. Nat Immunol 2010, 11:225-231.
10. Christen U, Bender C, von Herrath MG: Infection as a cause of type 1 diabetes? Curr Opin Rheumatol 2012, 24(4):417-23.
11. Oldstone MB: Molecular mimicry and immune-mediated diseases. FASEB J 1998, 12(13):1255-1265.
12. Hiemstra HS, van Veelen PA, Geluk A, Schloot NC, de Vries RR, Ottenhoff TH, Roep BO, Drijfhout JW: Limitations of homology searching for identification of T-cell antigens with library derived mimicry epitopes. Vaccine 1999, 18(3-4):204-8.
13. Schloot NC, Willemen SJ, Duinkerken G, Drijfhout JW, de Vries RR, Roep BO: Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsack-ie or proinsulin peptides do not crossreact with homologous coun-terpart. Hum Immunol 2001, 62(4):299-309.
14. Roep, BO, Hiemstra HS, Schloot NC, De Vries RRP, Chaudhuri A, Behan PO, Drijfhout JW: Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and Human cytomegalovirus but not Coxsackie virus. Ann NY Acad Sci 2002, 958: 163-165.
15. Gojanovich GS, Murray SL, Buntzman AS, Young EF, Vincent BG, Hess PR: Use of Peptide-Major-Histocompatibility-Complex Multi-mers in Type 1 Diabetes Mellitus. J Diab Sci Tech 2012, 6:515-524.
16. Nepom GT, Buckner JH, Novak EJ, Reichstetter S, Reijonen H, Gebe J, Wang R, Swanson E, Kwok WW: HLA class II tetramers: tools for direct analysis of antigen-specific CD4+ T cells. Arthritis Rheum 2002, 46(1):5-12.
17. Khalil I, d'Auriol L, Gobet M, Morin L, Lepage V, Deschamps I, Park MS, Degos L, Galibert F, Hors J: A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 1990, 85:1315-1319.
18. She JX: Susceptibility to type I diabetes: HLA-DQ and DR revisit-ed. Immunol Today 1996, 17:323-329.
19. Todd JA, Acha-Orbea H, Bell JI, Chao N, Fronek Z, Jacob CO, McDer-mott M, Sinha AA, Timmerman L, Steinman L: A molecular basis for MHC class II-associated autoimmunity. Science 1988, 240:1003-1009.
20. Van der Auwera B, Van Waeyenberge C, Schuit F, Heimberg H, Vandewalle C, Gorus F, Flament J: DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501- DQB1*0201 genotype. Belgian Diabetes Registry. Diabetes 1995, 44:527-530.
21. Mosaad YM, Auf FA, Metwally SS, Elsharkawy AA, El-Hawary AK, Hassan RH, Tawhid ZE, El-Chennawi FA: HLA-DQB1* alleles and genetic susceptibility to type 1 diabetes mellitus. World J Diabetes 2012, 3(8):149-155.
22. Atkinson MA, Leiter EH: The NOD mouse model of diabetes: As good as it gets? Nature Medicine 1999, 5:601-604.
23. Hattori M, Buse JB, Jackson RA, Glimcher L, Dorf ME, Minami M, Makino S, Moriwaki K, Kuzuya H, Imura H, et al: The NOD mouse: Recessive diabetogenic gene in the major histocompatibility complex. Science 1986, 231:733-735.
24. Oling V, Marttila J, Ilonen J, Kwok W, Nepom G, Knip M, Simell O, Reijonen H: GAD65-and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J Autoimmun 2005, 25(0896-8411):235-43.
25. Masewicz SA, Papadopoulos GK, Swanson E, Moriarity L, Moustakas AK, Nepom GT: Modulation of T cell response to hGAD65 peptide epitopes. Tissue Antigens 2002, 59:101-12.
26. Reijonen H, Kwok W, Nepom GT: Detection of CD4+ autoreactive T cells in T1D using HLA class II tetramers. Ann N Y Acad Sci 2003, 1005:82-87.
27. Kim Y, Vaughan K, Greenbaum J, Peters B, Law M, Sette A: A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV). PLoS ONE 2012, 7(5):e38028.
28. Ponomarenko J, Papangelopoulos N, Zajonc DM, Peters B, Sette A, Bourne PE: IEDB-3D: structural data within the immune epitope database. Nucleic Acids Res 2011, D1164-70.
29. Zanin-Zhorov A, Nussbaum G, Franitza S, Cohen IR, Lider O: T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. FASEB J 2003, 17(11):1567-9.
30. Vaughan K, Peters B, Larche M, Pomes A, Broide D, Sette A: Strate-gies to Query and Display Allergy-Derived Epitope Data from the Immune Epitope Database. Int Arch Allergy Immunol 2012, 160(4):334-345.
31. Abreu JR, Martina S, Verrijn Stuart AA, Fillié YE, Franken KL, Drijf-hout JW, Roep BO: CD8 T cell auto reactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity. Clin Exp Immunol 2012, 170(1):57-65.
32. Scotto M, Afonso G, Østerbye T, Larger E, Luce S, Raverdy C, Novelli G, Bruno G, Gonfroy-Leymarie C, Launay O, Lemonnier FA, Buus S, Carel JC, Boitard C, Mallone R: HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexes. Diabetes 2012, 61(10):2546-2555.
33. Kim Y, Ponomarenko J, Zhu Z, Tamang D, Wang P, Greenbaum J, Lundegaard C, Sette A, Lund O, Bourne PE, Nielsen M, Peters B: Immune epitope database analysis resource. Nucleic Acids Res 2012, 40:W525-30.